We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+38.97%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$670M
AUM Growth
+$90.6M
(+16%)
Cap. Flow
-$42.2M
Cap. Flow
% of AUM
-6.3%
Top 10 Holdings %
Top 10 Hldgs %
36.6%
Holding
80
New
17
Increased
16
Reduced
32
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aprea Therapeutics
APRE
|
+$40.5M |
| 2 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$14.7M |
| 3 |
Boston Scientific
BSX
|
+$12.4M |
| 4 |
Teleflex
TFX
|
+$10M |
| 5 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$9.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WMGI
Wright Medical Group Inc
WMGI
|
+$21.9M |
| 2 |
Teladoc Health
TDOC
|
+$17.3M |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$17.2M |
| 4 |
APLS
Apellis Pharmaceuticals
APLS
|
+$15M |
| 5 |
Novartis
NVS
|
+$12.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 80.45% |
| 2 | Industrials | 5.08% |
| 3 | Technology | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Vertex Pharmaceuticals
VRTX
$123B
| $3.52M | 0.53% |
16,071
+1,900
| +13% | +$385K |
|
52
Gilead Sciences
GILD
$165B
| $3.34M | 0.5% |
51,350
-195,590
| -79% | -$12.7M |
|
53
Illumina
ILMN
$29.5B
| $3.23M | 0.48% |
+10,023
| New | +$3.04M |
|
|
ALXN
54
DELISTED
Alexion Pharmaceuticals
ALXN
| $2.75M | 0.41% |
25,399
-11,300
| -31% | -$1.21M |
|
|
EVLO
55
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $2.57M | 0.38% |
31,629
-5,000
| -14% | -$559K |
|
56
Vericel Corp
VCEL
$2.38B
| $2.4M | 0.36% |
+138,000
| New | +$2.35M |
|
57
MeiraGTx Holdings
MGTX
$1.08B
| $1.87M | 0.28% |
93,306
-112,000
| -55% | -$1.92M |
|
|
SGEN
58
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.71M | 0.26% |
+15,000
| New | +$1.59M |
|
59
Agios Pharmaceuticals
AGIO
$2.08B
| $1.63M | 0.24% |
34,100
-11,300
| -25% | -$427K |
|
60
Incyte
INCY
$25.8B
| $1.31M | 0.2% |
+15,000
| New | +$1.28M |
|
|
PHAS
61
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $1.09M | 0.16% |
178,000
-18,000
| -9% | -$74.1K |
|
62
Q32 Bio
QTTB
$435M
| $904K | 0.13% |
2,427
-1,705
| -41% | -$488K |
|
63
Dr. Reddy's Laboratories
RDY
$9.8B
| $631K | 0.09% |
77,770
-119,215
| -61% | -$941K |
|
|
SAGE
64
DELISTED
Sage Therapeutics
SAGE
| $552K | 0.08% |
7,650
-2,850
| -27% | -$351K |
|
65
Cogent Biosciences
COGT
$6.76B
| $106K | 0.02% |
36,686
-343,108
| -90% | -$1.4M |
|
|
66
Novartis
NVS
$302B
| – | – |
-147,846
| Closed | -$12.8M |
|
67
Pfizer
PFE
$143B
| – | – |
-193,439
| Closed | -$6.59M |
|
68
Savara
SVRA
$1.08B
| – | – |
-710,310
| Closed | -$1.88M |
|
69
UroGen Pharma
URGN
$1.97B
| – | – |
-65,063
| Closed | -$1.55M |
|
|
SWAV
70
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| – | – |
-573,434
| Closed | -$17.2M |
|
|
VRAY
71
DELISTED
ViewRay, Inc.
VRAY
| – | – |
-1,240,865
| Closed | -$3.6M |
|
|
OBSV
72
DELISTED
ObsEva SA Ordinary Shares
OBSV
| – | – |
-643,151
| Closed | -$5.36M |
|
|
FSTX
73
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| – | – |
-69,164
| Closed | -$952K |
|
|
ALBO
74
DELISTED
Albireo Pharma Inc
ALBO
| – | – |
-147,211
| Closed | -$2.94M |
|
|
XLRN
75
DELISTED
Acceleron Pharma
XLRN
| – | – |
-227,596
| Closed | -$8.99M |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
AAA
TGM
Sectoral Asset Management's Q4 2019 Portfolio in Review
As of Q4 2019, Sectoral Asset Management held 80 positions worth $670M, up 16% from $580M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Sectoral Asset Management withdrew a net $42.2M in Q4 2019, closing 15 positions and reducing 32 holdings. Its most notable exit was Wright Medical Group Inc, an estimated $21.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 80% of assets, down from 84% a quarter earlier, followed by Industrials and Technology.
Against the trend, Sectoral Asset Management opened a new position in Aprea Therapeutics worth $67.5M.
- Sectoral Asset Management's largest Q4 2019 buy was Aprea Therapeutics: 73,517 shares worth $67.5M.
- Sectoral Asset Management added most to Boston Scientific in Q4 2019, an estimated $12.4M increase.
- Sectoral Asset Management's biggest Q4 2019 reduction was Teladoc Health, cutting an estimated $17.3M.
- Sectoral Asset Management fully exited Wright Medical Group Inc in Q4 2019, selling an estimated $21.9M.
- Sectoral Asset Management's ten largest holdings make up 37% of its $670M portfolio in Q4 2019.
- Sectoral Asset Management opened 17 new positions and closed 15 in Q4 2019.
- Sectoral Asset Management's portfolio value rose 16% quarter-over-quarter to $670M.
Based on Sectoral Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.